A Phase II Randomized Control Trial of Triapine Plus Lutetium Lu 177 Dotatate Versus Lutetium Lu 177 Dotatate Alone for Well-Differentiated Somatostatin Receptor-Positive Neuroendocrine Tumors.
In: Hepatitis Weekly, 2023-02-27, S. 56-56
serialPeriodical
Zugriff:
Giving triapine in combination withlutetium Lu 177 dotatate may be more effective at shrinking tumors orslowing tumor growth in patients with metastatic neuroendocrine tumorsthan the standard therapy of lutetium Lu 177 dotatate alone. Giving triapine incombination with lutetium Lu 177 dotatate may be more effective atshrinking tumors or slowing tumor growth in patients with metastaticneuroendocrine tumors than the standard therapy of lutetium Lu 177dotatate alone." DNA Viruses - Hepatitis B Virus Staff editors report on the newly launched clinical trial,NCT05724108, which has the following summary description: "This phase IItrial compares the effect of adding triapine to lutetium Lu 177 dotatateversus lutetium Lu 177 dotatate alone (standard therapy) in shrinkingtumors or slowing tumor growth in patients with neuroendocrine tumorsthat have spread from where they first started (primary site) to otherplaces in the body (metastatic). [Extracted from the article]
Copyright of Hepatitis Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
A Phase II Randomized Control Trial of Triapine Plus Lutetium Lu 177 Dotatate Versus Lutetium Lu 177 Dotatate Alone for Well-Differentiated Somatostatin Receptor-Positive Neuroendocrine Tumors.
|
---|---|
Zeitschrift: | Hepatitis Weekly, 2023-02-27, S. 56-56 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1086-0223 (print) |
Schlagwort: |
|
Sonstiges: |
|